New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…
MBX Biosciences to Provide Topline Results from its Phase 2 Trial of Potential Once-Weekly Canvuparatide for Hypoparathyroidism (HP) on Monday, September 22
September 19, 2025 16:18 ET | Source: MBX Biosciences, Inc. CARMEL, Ind.,…
Bioxodes positive Phase 2a stroke data show breakthrough potential of innovative therapeutic candidate BIOX-101
Safety endpoint met, with encouraging signs of efficacy in trial with 23…
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by…
MLK Listed on Binance Alpha, Spotlighting Its Global Loyalty Platform Potential
- MLK listed on Binance Alpha on August 16, highlighting service reliability…
100 Days to 8th CIIE: Preps Harden as Global Exhibitors Eye Business Potential in China
SHANGHAI, July 27, 2025 /PRNewswire/ -- Facing the complex international landscape and mounting…
HDFC Life Celebrates 25th AGM; Chairman Keki Mistry Highlights Industry Potential and Strong Company Performance
MUMBAI, India, July 17, 2025 /PRNewswire/ -- At its 25th Annual General…
UAE Approves BioAros Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health
CALGARY, Alberta, July 08, 2025 (GLOBE NEWSWIRE) -- In a significant move…
KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
July 07, 2025 08:00 ET | Source: KALA BIO, Inc. ARLINGTON, Mass.,…
